Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study

Fig. 1

FIT for Lynch Study Schematic. * = Per the inclusion criteria, eligible patients with MLH1 OR MSH2 pathogenic variants must be between 25 and 73 years of age, whereas eligible patients with pathogenic variants in PMS2, MSH6, or EPCAM must be between 35 and 73 years of age

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us